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1 These authors contributed equally.The basic components and mechanisms of mitochondrial transcription in mammals have been
described, however, the components involved in mRNA processing, translation and stability remain
largely unknown. In plants, pentatricopeptide domain RNA-binding proteins regulate the stability,
expression and translation of mitochondrial transcripts. Here, we investigated the role of an
uncharacterized mammalian pentatricopeptide domain protein, pentatricopeptide repeat domain
protein 3 (PTCD3), and showed that it is a mitochondrial protein that associates with the small sub-
unit of mitochondrial ribosomes. PTCD3 knockdown and over expression did not affect mitochon-
drial mRNA levels, suggesting that PTCD3 is not involved in RNA processing and stability. However,
lowering PTCD3 in 143B osteosarcoma cells decreased mitochondrial protein synthesis, mitochon-
drial respiration and the activity of Complexes III and IV, suggesting that PTCD3 has a role in mito-
chondrial translation.
Structured summary:
MINT-7033995: PTCD3 (uniprotkb:Q96EY7) associates (MI:0914) with MRPS15 (uniprotkb:P82914) by
tandem afﬁnity puriﬁcation (MI:0676)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mammalian mitochondrial DNA (mtDNA) is a circular, double
stranded, minimal genome that encodes 22 tRNAs, two rRNAs,
and 13 protein subunits of the electron transport chain complexes
[1]. Consequently, humanmtDNA is dependent on nuclear encoded
proteins for replication, repair, transcription and translation. This
dependency is evident in several human diseases that are caused
by defects of mtDNA maintenance and expression [2]. Very little
is known about the regulation of mitochondrial gene expression
and how it affects mitochondrial function in health and disease
[3,4]. This is particularly important since tissue-, cell- and dis-
ease-speciﬁc variations have been observed in the levels of differ-
ent mitochondrial RNAs and the proteins they encode, but cannot
be explained at present [5–8]. Mitochondrial RNAs are transcribedchemical Societies. Published by E
D3, pentatricopeptide repeat
ipovska).as long polycistronic, precursor transcripts that generally encom-
pass the entire mtDNA and are processed by removing interspersed
tRNAs to release the individual mRNAs and rRNAs [9]. The levels of
the 13 individual mRNAs and their proteins must be controlled at a
post-transcriptional level, although little is known about how
these RNAs are regulated in mammalian mitochondria.
Pentatricopeptide repeat (PPR) domain proteins were identiﬁed
ﬁrst in plants, where they constitute a large family of mitochon-
drial and plastid proteins involved in transcript processing, editing
and translation [10]. In mammals, there are seven identiﬁed mito-
chondrial PPR domain proteins, the mitochondrial RNA polymerase
(POLRMT), the leucine-rich PPR cassette (LRPPRC) protein, mito-
chondrial ribosomal protein of the small subunit 27 (MRPS27),
PPR domain proteins (PTCD) 1, 2, and 3 and mitochondrial RNase
P protein 3 (MRPP3), which is a recently identiﬁed subunit of the
mammalian mitochondrial RNase P complex [11,12]. Mutation of
the LRPPRC gene has been shown to decrease cytochrome oxidase
(COX) I and III mRNAs [13], and is the cause for the rare French–
Canadian variant of Leigh syndrome, a debilitating neurodegenera-
tive condition resulting from mitochondrial cytochrome c oxidase
deﬁciency [14]. Recently, the PPR domain protein PTCD2 waslsevier B.V. All rights reserved.
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we have investigated the role of the previously uncharacterized
mammalian pentatricopeptide repeat domain protein 3 (PTCD3)
and shown that it associates with the small subunit of the mito-
chondrial ribosome and is important for mitochondrial translation.
We show that by decreasing PTCD3, we lower the translation of
mitochondrial encoded proteins and consequently observe a de-
creased activity of Complexes III and IV and decreased mitochon-
drial respiration.
2. Materials and methods
2.1. Plasmid expression vectors
All expression vectors were based on pcDNA3 (Invitrogen). Full
length human PTCD3 (NCBI accession number NP_060422) was ex-
pressed fused to a C-terminal tandem afﬁnity puriﬁcation tag (tan-
dem afﬁnity puriﬁcation (TAP), derived from pCeMM-CTAP(SG),
obtained from EUROSCARF, ABO76910) [16], or EYFP (BD Biosci-
ences) at the C-terminus. Plasmids were tested for expression by
transfection and immunoblotting.
2.2. Cell culture
143B Osteosarcoma cells were cultured at 37 C under humidi-
ﬁed 95% air/5% CO2 in Dulbecco’s modiﬁed Eagle’s medium
(DMEM, Invitrogen) containing glucose (4.5 g l1), 1 mM pyruvate,
2 mM glutamine, penicillin (100 U ml1), streptomycin sulfate
(100 lg ml1) and 10% fetal bovine serum (FBS).
2.3. Mitochondrial isolation
Mitochondria were prepared from 107 cells grown overnight in
15 cm dishes and isolated as described previously [17].
2.4. Transfections
143B Cells were plated at 60% conﬂuence in six-well plates or
10 cm dishes and transfected with annealed siRNAs or mammalian
expression plasmids in OptiMEM media (Invitrogen). 125 nM (for
six-well plates) or 145 nM (for 10 cm dishes) of PTCD3 or control,
non-targeting siRNAs (Dharmacon) were transfected using Lipo-
fectamine 2000 (Invitrogen). 158 ng/cm2 of PTCD3 or control EYFP
plasmid DNA was transfected using Fugene HD (Roche). Cell incu-
bations were carried out for up to 72 h following transfection or
cells were re-seeded and re-transfected for another 72 h for 6-
day transfections. PTCD3 expression was measured by quantitative
reverse transcriptase (RT)-PCR.
2.5. Fluorescence cell microscopy
For immunocytochemistry 143B cells were plated onto 13 mm
diameter glass coverslips and allowed to attach overnight. Cells
were transfected with pPTCD3-EYFP for 48 h, and at the end of
the incubation treated with 100 nM Mitotracker Orange for
15 min then washed with Tris buffered saline (5 mM Tris/HCl
(pH 7.4), 20 mM NaCl, TBS). Cells were mounted in DABCO/PVA
medium. Images were acquired using an Olympus DP70 ﬂuores-
cent inverted microscope using a Nikon 40 objective.
2.6. Afﬁnity puriﬁcation and RNA isolation
143B Cells (2.5  107) were lysed in 50 mM Tris/HCl (pH 7.5),
125 mM NaCl, 5% glycerol, 1% Igepal CA-630, 1.5 mM MgCl2,
1 mM DTT, 25 mM NaF, 1 mM Na3VO4, 1 mM EDTA, 1  Complete
protease inhibitors (Roche), 200 U ml1 RNaseOUT (Invitrogen) at
4 C. The lysate was cleared by centrifugation and incubated withrabbit-IgG agarose (Sigma) at 4 C for 2 h. The agarose was washed
with lysis buffer and then with cleavage buffer (10 mM Tris/HCl
(pH 7.5), 150 mM NaCl, 0.5 mM EDTA, 1% Igepal CA-630,
200 U ml1 RNaseOUT) and protein was eluted by addition of
0.25 U ll1 of AcTEV protease (Invitrogen, RT for 1 h). RNA was iso-
lated using the miRNeasy Mini kit (Qiagen) incorporating an on-
column RNase-free DNase digestion to remove all DNA. For protein
isolation 5  107 143B cells were used and the PTCD3 was isolated
and eluted as described above, then bound to Ultralink Immobi-
lized Streptavidin Plus beads (Pierce), washed with cleavage buffer
and eluted in cleavage buffer containing 1 mM D-biotin. The
MRPS15 protein associated with PTCD3 was detected by
immunoblotting.
2.7. Tiling array analysis of mitochondrial RNA
Microarray analysis was performed using Affymetrix GeneChip
Human Mitochondrial Resequencing arrays, version 2.0. cDNA was
prepared from the entire sample of total RNA puriﬁed from TEV
eluted PTCD3 or EYFP as described in the Affymetrix GeneChip
Whole Transcript (WT) Double-Stranded Target Assay Manual. Ar-
ray washing, staining, and scanning was performed as described in
the Affymetrix GeneChip Whole Transcript (WT) Double-
Stranded Target Assay Manual, using an Affymetrix Hybridization
Oven 640, an Affymetrix Fluidics Station 450 and an Affymetrix
GeneChip Scanner 3000 7G. All .CEL ﬁles were analysed using the
Affymetrix GSeq 4.1 software. As expected, the background ﬂuo-
rescence and the TaglQ-EX controls were found to be comparable
between PTCD3 and EYFP experiments. The data are presented as
a ratio of ﬂuorescence detected in the PTCD3 associated RNA sam-
ple to that detected in the EYFP sample.
2.8. Quantitative RT-PCR
The abundance of mitochondrial transcripts was measured on
RNA isolated from 2  106 143B cells using the miRNeasy RNA
extraction kit (Qiagen). Levels of PTCD3 mRNA were measured
from RNA isolated from normal human tissues and pooled (Ambi-
on). Each pool is comprised of RNA from at least three tissue do-
nors and the integrity of the RNA was veriﬁed by capillary
electrophoresis using an Agilent 2100 bioanalyzer and quantitated
using a NanoDrop spectrophotometer. cDNA was prepared from
2 lg of RNA using ThermoScript reverse transcriptase (Invitrogen)
and random hexamers and used as a template in the subsequent
PCR that was performed using a Corbett Rotorgene 3000 using
Platinum UDG SYBR Green mastermix (Invitrogen) and normalized
to 18S ribosomal RNA.
2.9. Sucrose gradient centrifugation
Mitochondria isolated from 143B cells (0.25 mg) were lysed in a
buffer as described in [18], 20 mM Tris, 10 mMmagnesium acetate,
pH 7.5, supplemented with 1 mM PMSF, 0.1% SDS and 1.6% Triton-
X 100 for 30 min, the lysate centrifuged at 10 000g for 10 min, the
clariﬁed lysate was loaded on a 3.5 mL continuous 15–30% sucrose
gradient (in 20 mM Tris, 10 mM magnesium acetate, pH 7.5, sup-
plemented with 1 mM PMSF) and centrifuged at 100 000g for
16 h using a SW60 Ti rotor in an Optima Beckman Coulter prepara-
tive ultracentrifuge. Fractions were collected and precipitated with
40% trichloroacetic acid, washed in acetone, and the entire fraction
was resolved by SDS–PAGE. The ribosomal subunits and PTCD3-
TAP were detected by immunoblotting.
2.10. Immunoblotting
Speciﬁc proteins were detected using rabbit aMRPL11 (NEB, di-
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Fig. 1. PTCD3 is a mitochondrial protein with 9 PPR domains. (A) Gene structure of
PTCD3. (B) mRNA distribution in normal human tissues analysed by Q RT-PCR. (C)
143B cells transfected with pPTCD3-EYFP. PTCD3-EYFP (green) was co-localized to
mitochondria stained with Mitotracker orange (red) directly by ﬂuorescence
microscopy and the overlaid image (yellow) indicates co-localization of PTCD3
with mitochondria.
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in 5% skim milk powder in phosphate-buffered saline (4.3 mM so-
dium phosphate, dibasic, 137 mM sodium chloride, 2.7 mM potas-
sium chloride, 1.4 mM potassium phosphate, monobasic, PBS),
0.05% Tween-20. Control immunoblots for MnSOD in the fractions
from the sucrose gradient were detected using a mouse antibody
(BD Transduction Laboratories, diluted 1:2000). The primary anti-
bodies were detected using goat anti-mouse or goat anti-rabbit
horse radish peroxidase (Biorad, diluted 1:10 000). PTCD3-TAP
was detected using goat anti-mouse HRP.
2.11. Mitochondrial protein synthesis
143B Cells were grown in six-well plates until 60% conﬂuent,
transfected and 3 days later de novo protein synthesis was ana-
lyzed. The growth medium was replaced with methionine and cys-
teine free medium containing 10% dialysed FBS for 30 min before
addition of 100 lg ml1 emetine for 5 min. Next, 200 lCi Ex-
pres35S Protein Labeling Mix [35S] (14 mCi, Perkin–Elmer) was
added and incubated at 37 C for 1 h, then washed in PBS and cen-
trifuged. The cells were suspended in PBS and 20 lg of proteins
were separated on 12.5% SDS–PAGE and the radiolabeled proteins
were visualized on ﬁlm.
2.12. Respiration
State 3 respiration using 0.5 mM TMPD and 2 mM ascorbate
was measured in permeabilized cells according to Kuznetsov
et al. [19].
2.13. Complex enzyme assays
Enzyme assays of citrate synthase, complex III and complex IV
were carried out in a 1 ml cuvette at 30 C using a Perkin–Elmer
lambda 35 dual beam spectrophotometer as described before [20].3. Results
3.1. PTCD3 is a mitochondrial protein with nine PPR domains
The most distinctive features of PTCD3 are its nine PPR domains
and an N-terminal mitochondrial targeting sequence (Fig. 1A). We
measured the mRNA levels of PTCD3 in human tissues and found
that it is most abundant in testes, skeletal muscle and heart tissue
(Fig. 1B). We fused the C-terminus of the protein to EYFP and
showed that PTCD3 localizes speciﬁcally to mitochondria in 143B
cells (Fig. 1C).3.2. PTCD3 is a mitochondrial RNA-binding protein
We fused the C-terminus of PTCD3 to a tandem afﬁnity puriﬁca-
tion (TAP) tag and expressed this protein in 143B osteosarcoma
cells. We used the TAP tag to isolate the PTCD3-TAP protein from
cells and measured the enrichment of mitochondrial mRNA tran-
scripts using a human mtDNA re-sequencing array. We adapted
the re-sequencing array for use as a single nucleotide tiling array
of the complete mitochondrial genome to detect RNAs that were
associated with PTCD3 compared to a control puriﬁcation of EYFP.
The ﬂuorescence was strikingly higher for the 930 probes that tile
the 12S rRNA region (Fig. 2A).
To conﬁrm the RNA targets of PTCD3, quantitative reverse
transcriptase PCR (Q RT-PCR) was carried out on RNA pulled down
from the TAP. There was an over 25-fold enrichment observed only
for the 12S rRNA transcript and not the remaining mitochondrial
transcripts compared to the control EYFP-TAP protein (Fig. 2B). Be-cause many plant PPR domain proteins are involved in processing
of organelle transcripts [10], we investigated if PTCD3 bound the
junction between the 12S rRNA and the 16S rRNA. We found that
there was no signiﬁcant enrichment observed of this junction tran-
script compared to the control EYFP-TAP protein (Fig. 2B).
We analysed if PTCD3 associated with mitochondrial ribosomes
by separating mitochondrial lysates on a 15–30% continuous su-
crose gradient and immunoblotting against protein markers of
the small and large subunits of the ribosome. PTCD3 co-migrated
predominantly with the small ribosomal subunit protein 15
(MRSP15) suggesting that PTCD3 associates with the small subunit
of mitochondrial ribosomes (Fig. 2C). In addition, we isolated
PTCD3 that was expressed in 143B cells using the TAP tag and by
immunoblotting found that MRSP15 was enriched with PTCD3
but not with the control EYFP isolation (Fig. 2D), suggesting further
that PTCD3 associates with the mitochondrial small ribosomal
subunit.
3.3. PTCD3 has a role in mitochondrial translation but not in RNA
metabolism
We investigated the effects of PTCD3 knockdown and overex-
pression in 143B cells. We found that the PTCD3 directed siRNA
duplex signiﬁcantly lowered the mRNA levels of PTCD3 (Fig. 3A in-
set) but did not affect the abundance of the mature mitochondrial
RNA transcripts (Fig. 3A). Overexpression of PTCD3 increased its
mRNA abundance over 170-fold, however, it did not change the
levels of the mitochondrial RNAs. The junction between the 12S
rRNA and the 16S rRNA was not affected by PTCD3 knockdown
and overexpression (Fig. 3A). This suggested that PTCD3 does not
affect the abundance or stability of precursor and mature mito-
chondrial rRNAs.
We investigated changes in de novo mitochondrial protein syn-
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Fig. 2. PTCD3 is a mitochondrial RNA-binding protein that associates with the 12S rRNA. PTCD3-TAP protein expressed in 143B cells was puriﬁed using rabbit-IgG agarose
and eluted by tobacco etch virus (TEV) protease cleavage. RNA associated with the eluted PTCD3-TAP was reverse transcribed and analysed by tiling microarray and by Q-PCR
analysis. Values are expressed as a ratio of PTCD3-TAP compared to a puriﬁcation from cells that expressed a control, EYFP-TAP protein. (A) Ratio of ﬂuorescence from cDNA
hybridized to a mitochondrial DNA tiling array. (B) Ratio of mitochondrial mRNA transcripts detected by Q RT-PCR. Data are means ± S.E.M. of three separate experiments. (C)
Mitochondria from cells transfected with PTCD3-TAP were lysed and resolved on 15–30% continuous sucrose gradients to determine the protein distribution relative to
mitochondrial ribosomal proteins that are markers of the mitochondrial large (MRPL11) and small subunit (MRPS15). The blot was re-probed for MnSOD as a control. (D)
PTCD3 and EYFP were puriﬁed using the TAP tag and the association with the mitochondrial small subunit was assessed by immunoblotting using an aMRPS15 antibody. The
presence of PTCD3 or EYFP in the eluates was determined using an amyc antibody.
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chondrial proteins. We observed a signiﬁcant overall decrease of
mitochondrial protein synthesis when PTCD3 was knocked down
in cells compared to non-targeting siRNAs and non transfected
cells (Fig. 3B). This suggests that PTCD3 has a role in mitochondrial
translation.
We have investigated the abundance of marker proteins for the
small and large mitochondrial ribosomal subunits (MRPS15 and
MRPL11) after siRNA knockdown of PTCD3 and control siRNA after
3 and 6 days, respectively, and found the levels of these proteins
were unaffected by the reduction of PTCD3 (Fig. 3C). It has previ-
ously been shown that the loss of core mitochondrial small ribo-
somal subunit proteins causes the loss or reduction of other
small ribosomal subunit proteins [21]. This data suggest that ribo-
some assembly is not affected by the decrease in PTCD3 levels.
3.4. PTCD3 knockdown leads to a decrease in mitochondrial
respiration and activity of the respiratory complexes
Because we observed a signiﬁcant decrease in the abundance of
mitochondrial encoded proteins when PTCD3 was knocked down,
we measured mitochondrial oxygen consumption and the respira-
tory complex activities in 143B cells where PTCD3 was knocked
down or overexpressed. The respiration of mitochondria in digito-
nin-permeabilized cells was signiﬁcantly lowered when PTCD3was knocked down after 3 and 6 days but not when PTCD3 was
overexpressed (Fig. 3D and E). PTCD3 knockdown led to decreased
activity of Complex III after 3 days and this was even more pro-
nounced after 6 days (Fig. 3F). Similarly, a decrease in Complex
IV activity was observed after a 3-day knockdown of PTCD3 and
this decrease was more dramatic after 6 days (Fig. 3G). Overexpres-
sion of PTCD3 did not affect the activity of these complexes.
4. Discussion
In this study, we show that PTCD3 is a mitochondrial protein
that is more abundant in mitochondria-rich tissues. The predicted
PPR domains may give PTCD3 RNA-binding afﬁnity for the 12S
rRNA that was detected in the tiling array. In addition, we found
that PTCD3 associated with the small subunit of mitochondrial
ribosomes. This corroborates a previous proteomic study of the
28S small ribosome subunit of bovine mitochondria that identiﬁed
several proteins including a homolog of PTCD3 [22]. Overexpres-
sion and knockdown of PTCD3 in cells did not affect the abundance
or processing of mitochondrial transcripts, however knockdown of
PTCD3 signiﬁcantly decreased protein synthesis of mitochondrial
encoded polypeptides. Consequently, we observed lowered respi-
ration and decreased activities of Complex III and Complex IV fol-
lowing a 3–6 day knockdown of PTCD3. Overexpression of PTCD3











































































































































































































































































Fig. 3. PTCD3 affects mitochondrial protein synthesis and consequently mitochon-
drial function, but not mitochondrial transcript levels and processing. (A) RNA
isolated from cells transfected with PTCD3 siRNA, non-targeting siRNA, pPTCD3-
TAP, pEYFP-TAP was analysed by Q RT-PCR. The data is expressed as a ratio of
transcript abundance from experimental samples compared to control samples.
Ampliﬁcation of mitochondrial mRNA transcripts is shown. Data are means ± S.E.M.
of three separate experiments. (B) Mitochondrial protein synthesis is lowered when
PTCD3 abundance is decreased in cells. The protein synthesis of cytoplasmic
proteins was inhibited with emetine, allowing the incorporation of 35S-labeled
methionine and cysteine in the 13 mitochondrial proteins synthesized by the
mitochondrial ribosomes. 143B Cells were transfected with siRNAs targeting
PTCD3, non-targeted siRNAs as control, PTCD3-TAP and EYFP-TAP as control. Equal
amounts of cell lysate protein (20 lg) were separated on 12.5% SDS–polyacrylamide
gels and visualized on ﬁlm. Data are representative of six independent experiments
with the same outcome. (C) 143B Cells were transfected with siRNAs targeting
PTCD3 and non-targeted siRNAs as controls for 3 and 6 days, mitochondria were
isolated and the abundance of protein markers for the mitochondrial small and
large ribosomal subunit were detected by immunoblotting using antibodies for the
MRSP15 and MRLP11 proteins. (D and E) State 3 respiration on ascorbate/TMPD was
measured in digitonin-permeabilized 143B cells using an oxygen electrode. Oxygen
consumption is shown as percent of the control treatment with transfection reagent
only and the decrease in respiration is signiﬁcant compared to the control and non-
targeting siRNA treatment after 3 and 6 days, respectively. Enzyme activities of
Complex III (F) and Complex IV (G) of mitochondria isolated from 143B cells
transfected with PTCD3 siRNA, non-targeting siRNA, PTCD3-TAP and EYFP-TAP
were measured spectrophotometrically. Enzyme activity is shown as ratios of
complex activity compared to citrate synthase activity. Data are means ± S.E.M. of
three–ﬁve separate experiments; *P < 0.05 compared with control treatments by a
two-tailed paired Student’s t-test.
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etric amounts to mitochondrial ribosomes and increasing the
amount of PTCD3 cannot further stimulate mitochondrial transla-
tion. This indicates that PTCD3 is necessary for efﬁcient mitochon-
drial translation, however its exact role is yet to be elucidated. The
association of PTCD3 with the 12S rRNA and the small subunit of
mitochondrial ribosomes raises the question of whether PTCD3 is
an RNA-binding protein of the 12S rRNA and as such is a bona ﬁde
ribosomal protein, or if it is a transiently associated small subunit
translational regulator that may be involved in the recognition or
decoding of mRNA transcripts.
In yeast, mitochondrial transcripts have 50 untranslated regions
that bind translational activators, however, these are not con-
served in mammals [23]. Because mammalian mitochondrial
mRNAs begin at the start codon and lack 50 untranslated regions
or Shine-Dalgarno sequences [22], mitochondrial ribosomes must
have evolved an alternative way to regulate translation initiation
and to ensure accurate start codon recognition. Comparative stud-
ies of the mammalian mitochondrial ribosome with bacterial and
cytoplasmic ribosomes of eukaryotes have identiﬁed large varia-
tions in the composition and number of mitochondrial ribosomal
subunits [24,25] and the number of additional ribosomal subunits
may increase to include previously uncharacterized proteins such
as PTCD3. Core mitochondrial ribosomal proteins have been iden-
tiﬁed that are essential for the assembly of ribosomes in addition
to proteins that are not essential for ribosome assembly but are re-
quired for ribosomal function [21]. It may be that PTCD3 is a mito-
chondrial ribosome protein that is required for protein synthesis
but not for ribosome assembly. As part of the small ribosomal sub-
unit, PTCD3 may be important for structural integrity or it could
have a role in translation initiation and decoding. Further investi-
gation of the role of PTCD3 in mitochondrial ribosomes will pro-
vide insights into the regulation of mitochondrial translation.
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